This site is intended for healthcare professionals

Phase III clinical data from BE VIVID and BE READY studies of bimekizumab presented at AAD for treatment of psoriasis.- UCB.

Read time: 3 mins
Last updated:15th Jun 2020
Published:14th Jun 2020
Condition: Psoriasis
Type: drug
Register free for full access to